All In MedTech

FDA Clearance Tracker · P140003-S123

Impella 5.5 with SmartAssist System; Impella CP with SmartAssist System; Impella 2.5; Impella 5.0; Impella LD;

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140003-S123
Device name
Impella 5.5 with SmartAssist System; Impella CP with SmartAssist System; Impella 2.5; Impella 5.0; Impella LD;
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Feb 7, 2025
Decided
Aug 1, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

approval for modifying the Impella labeling to reflect the findings of the Impella Sodium Bicarbonate Post-Approval Study

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.